美女免费一级视频在线观看
Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine advisory panel is expected to vote for changes to the MMR and hepatitis vaccine schedules. The panel convened for a two-day discussion around shots for COVID-19, hepatitis B and chickenpox. (Chicago Tribune)
Novo Nordisk cut its U.S. obesity education team. The team included several hundred staff who were reportedly told that their roles would be terminated. (Reuters)
The Food and Drug Administration is reversing a rule that brought lab developed tests under the agency. The move is a formality after a federal district court decision. (Endpoints News)
Roche agreed to buy 89bio, a metabolic disease biotech, for up to $3.5 billion. This comes as the Swiss pharma giant builds up its obesity portfolio. (Axios)
Texas Governor Greg Abbott signed a bill cracking down on mail-in abortion pills. The measure empowers private citizens to sue to help police the abortion ban. (WTOP)
To read yesterday’s edition of Five things for pharma marketers to know, click here.